2-氰基-N-(3-甲氧基丙基)-乙酰胺 | 15029-45-5

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 中文名称: 2-氰基-N-(3-甲氧基丙基)-乙酰胺
• 英文名称: 2-cyano-N-(3-methoxy-propyl) acetamide
• 英文别名: N-(3-methoxypropyl)-2-cyanoacetylamide；2-cyano-N-(3-methoxypropyl)acetamide；N-(3-methoxypropyl)cyanoacetamide；N-(3-Methoxy-propyl)-cyanacetamid
• CAS: 15029-45-5
• 化学式: C₇H₁₂N₂O₂
• mdl: MFCD00118984
• 分子量: 156.184
• InChiKey: QWNFSBIGAWBUTF-UHFFFAOYSA-N

物化性质

• 沸点：
  359.1±27.0 °C(Predicted)
• 密度：
  1.042±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  -0.4
• 重原子数：
  11
• 可旋转键数：
  5
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.714
• 拓扑面积：
  62.1
• 氢给体数：
  1
• 氢受体数：
  3

安全信息

• 海关编码：
  2926909090

反应信息

• 作为反应物：
  描述：

  2-氰基-N-(3-甲氧基丙基)-乙酰胺 在 potassium hydroxide 作用下， 以 乙醇 、 水 为溶剂， 反应 4.05h， 生成 ethyl 4-[2-({7-hydroxy-3-[(3-methoxypropyl)carbamoyl]-5-oxo-4H,5H-thieno[3,2-b]pyridin-2-yl}sulfanyl)acetamido]benzoate
  参考文献：
  名称：

  取代的噻吩的组合合成的新区域选择性方法，噻吩并[3,2- b ]通过的“domino'型反应组合吡啶等杂环

  摘要：

  我们提出了一个新颖的组合多组区域选择性方法向噻吩并[3,2-的合成b ]吡啶化合物和吡啶吡喃。该方法基于“多米诺”型反应。该反应中的高区域选择性是由原位生成2-氰基-1- mercaptoethenethiolate的单钾盐获得。我们还证明了在该反应中使用2-氰基乙酸乙酯作为CH-酸导致在Dieckmann缩合步骤终止多米诺序列，并产生了新颖的3-（4-cyano-3-hydroxy-5-（烷硫基）噻吩-2-基）-3-氧代丙酸酯。

  DOI：

  10.1016/j.tet.2013.09.025
• 作为产物：
  描述：

  氰乙酸乙酯 、 3-甲氧基丙胺 以 水 为溶剂， 生成 2-氰基-N-(3-甲氧基丙基)-乙酰胺
  参考文献：
  名称：

  一种简单且通用的合成高度官能化的6-oxo-1,6-二氢吡啶的方法

  摘要：

  一锅反应中，由2-cyano-3的N-烷基和N-芳基衍生物有效合成了多种5-氰基-4-甲硫基-6-氧代-1,6-二氢吡啶-3-羧酸酯， 3-双（甲硫基）丙烯酰胺和某些β-酮酯。反应通过碳酸氢钾介导的β-酮酯向2-氰基-3,3-双（甲硫基）丙烯酰胺的共轭加成而进行，接着是甲硫醇的损失，接着酰胺基与酰基羰基的分子内缩合。通过分离2-乙酰基-4-氰基-5-氨基-3-（甲硫基）-5-氧opent-3-烯酸酯中间体并将其独立环化为所需的6-oxo-1，已经建立了反应机理。 ，6-二氢吡啶。

  DOI：

  10.1016/j.tet.2013.04.082

文献信息

• Synthesis of resveratrol acrylamides derivatives and biological evaluation of their anti-proliferative effect on cancer cell lines
  作者：Ban-Feng Ruan、Si-Qi Wang、Xiao-Lin Ge、Ri-Sheng Yao

  DOI：10.2174/15701808113109990057

  日期：2013.11

  A new series of resveratrol acrylamides amine derivatives was designed, synthesized, and evaluated for their anti-proliferative activity against three cancer cell lines including human chronic myelocytic leukemia cell K562, human hepatoma HuH-7 and human lung carcinoma A549. Most of the compounds showed superior activity against three cell lines when compared to parent resveratrol. C13 had the best anti-tumor activity against the HuH-7 cell line and its IC50 was 4.5 μmol/L; C16 had the best anti-tumor activity against the K562 cell line and its IC50 was 2.9 μmol/L; C18 had the best anti-tumor activity against the A549 cell line and its IC50 was 3.8 μmol/L. It could be seen that the activity of the aromatic amine derivatives was better than the fatty amine derivatives by analyzing the experimental data.

  设计、合成并评价了一系列白藜芦醇丙烯酰胺胺衍生物对三种癌细胞株的抗增殖活性，包括人慢性髓细胞白血病细胞K562、人肝癌HuH-7和人肺癌A549。与母体白藜芦醇相比，大多数化合物对三种细胞株表现出更强的活性。C13对HuH-7细胞株具有最佳的抗肿瘤活性，其IC50为4.5 μmol/L; C16对K562细胞株具有最佳的抗肿瘤活性，其IC50为2.9 μmol/L；C18对A549细胞株具有最佳的抗肿瘤活性，其IC50为3.8 μmol/L。通过分析实验数据可以发现，芳香胺衍生物的活性优于脂肪胺衍生物。
• Cyanoacetamide MCR (III): Three-Component Gewald Reactions Revisited
  作者：Kan Wang、Dabin Kim、Alexander Dömling

  DOI：10.1021/cc9001586

  日期：2010.1.11

  Cyanoacetic acid derivatives are the starting materials for a plethora of multicomponent reaction (MCR) scaffolds. Here we describe valuable general protocols for the synthesis of arrays of 2-aminothiophene-3-carboxamides from cyanoacetamides, aldehydes or ketones, and sulfur via a Gewald-3CR variation. In many cases the reactions involve a very convenient work up by simple precipitation in water and filtration

  氰基乙酸衍生物是大量多组分反应（MCR）支架的起始材料。在这里，我们描述了通过Gewald-3CR变异体从氰基乙酰胺，醛或酮和硫合成2-氨基噻吩-3-羧酰胺阵列的有价值的通用协议。在许多情况下，通过在水中简单沉淀和过滤，反应涉及非常方便的后处理。描述了40多种新产品。我们预见到我们的方案及其产生的衍生物对于极大地扩展氰基乙酰胺衍生物的MCR支架空间将变得非常有价值。
• MEROCYANINE DERIVATIVES
  申请人：BASF SE

  公开号：US20140150380A1

  公开（公告）日：2014-06-05

  Disclosed are compounds of formula (1) and (2) and/or E/E-, E/Z- or Z/Z geometrical isomer forms thereof; wherein R1-R5, R1-R11 and A are defined as in description. The compounds are used as UV absorbers for protecting household products from photolytic and oxidative degradation, as plastic additives, preferably for food and pharmaceutical packaging applications, for preventing photo-degradation of food by incorporation of the compounds of formula (1′) and/or (2′) into transparent food containers, for protection of UV-A sensitive drugs from photo-degradation by incorporation of UV absorber in transparent blister foils or transparent pharmacy containers, as additives for photographic and printing applications, as additives for electronic applications and protecting the ingredients in agriculture applications.

  揭示的是公式（1）和（2）的化合物和/或其E/E-、E/Z-或Z/Z几何异构体形式；其中R1-R5、R1-R11和A的定义如描述中所述。这些化合物被用作紫外线吸收剂，用于保护家用产品免受光解和氧化降解，作为塑料添加剂，优选用于食品和药品包装应用，通过将公式（1'）和/或（2'）的化合物并入透明食品容器中，防止食物的光降解，通过在透明泡罩箔或透明药品容器中并入紫外线吸收剂，保护UV-A敏感药物免受光降解，作为摄影和印刷应用的添加剂，作为电子应用的添加剂，并保护农业应用中的成分。
• [EN] MEROCYANINE DERIVATIVES<br/>[FR] DÉRIVÉS DE MÉROCYANINE
  申请人：BASF SE

  公开号：WO2013011480A1

  公开（公告）日：2013-01-24

  Disclosed are compounds of formula (1) and (2) and/or E/E-, E/Z- or Z/Z geometrical isomer forms thereof; wherein R1-R5, R1-R11 and A are defined as in description. The compounds are used as UV absorbers for protecting household products from photolytic and oxidative degradation, as plastic additives, preferably for food and pharmaceutical packaging applications, for preventing photo-degradation of food by incorporation of the compounds of formula (1 ') and/or (2') into transparent food containers, for protection of UV-A sensitive drugs from photo-degradation by incorporation of UV absorber in transparent blister foils or transparent pharmacy containers, as additives for photographic and printing applications, as additives for electronic applications and protecting the ingredients in agriculture applications.

  公开了式（1）和（2）的化合物及其E/E-、E/Z-或Z/Z几何异构体形式；其中R1-R5、R1-R11和A的定义如描述中所述。这些化合物被用作紫外线吸收剂，用于保护家庭产品免受光解和氧化降解的影响，作为塑料添加剂，优选用于食品和药品包装应用，通过将式（1'）和/或（2'）的化合物纳入透明食品容器中，防止食品的光降解，通过在透明泡罩箔或透明药房容器中加入紫外线吸收剂来保护对紫外线A敏感的药物免受光降解的影响，作为摄影和印刷应用的添加剂，作为电子应用的添加剂，并保护农业应用中的成分。
• COSMETIC AND/OR DERMATOLOGICAL COMPOSITION CONTAINING A MEROCYANINE DERIVATIVE COMPRISING SPECIFIC POLAR GROUPS CONSISTING OF HYDROXYL- AND ETHER-FUNCTIONALITIES
  申请人：Richard Herve

  公开号：US20140294743A1

  公开（公告）日：2014-10-02

  The present invention relates to a cosmetic and/or dermatological composition comprising in a physiologically acceptable medium at least one merocyanine derivative of formula (1) or (2) and/or its E,E-, E,Z- or Z,Z-geometrical isomer forms: comprising specific polar groups consisting of hydroxyl- and ether-functionalities. Another object of the present invention relates to a cosmetic process for controlling and/or improving the darkening of the skin under exposure to UV radiation and the homogeneity of the colour of the complexion which comprises the application onto the skin of a cosmetic composition as above defined. Another object of the present invention relates to a cosmetic process for protecting the keratinic materials and particularly the skin against photo-ageing which comprises the application onto the keratinic material of a cosmetic composition as above defined.

  本发明涉及一种化妆品和/或皮肤科学组合物，其在生理上可接受的介质中包含至少一种公式（1）或（2）的merocyanine衍生物及/或其E，E-，E，Z-或Z，Z-几何异构体形式：包括由羟基和醚功能团组成的特定极性基团。本发明的另一个目的涉及一种化妆过程，用于控制和/或改善皮肤在紫外线照射下的变黑和肤色均匀性，包括在皮肤上涂抹上述定义的化妆品组合物。本发明的另一个目的涉及一种化妆过程，用于保护角质素材料，特别是皮肤免受光老化的影响，包括在角质素材料上涂抹上述定义的化妆品组合物。